🔎 Trials Near Me

Home › Burkitt Lymphoma › Rhode Island › Providence

Burkitt Lymphoma clinical trials in Providence, RI

7 studies for Burkitt Lymphoma are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

RecruitingPhase 3
  • Rhode Island Hospital, Providence
Ages 18 to 39 · All sexes · Updated Oct 2, 2026 · NCT03150693

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

RecruitingPhase 1
  • Lifespan Cancer Institute at Rhode Island Hospital, Providence
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RecruitingPhase 2
  • Rhode Island Hospital, Providence
Ages 1 to 30 · All sexes · Updated Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RecruitingPhase 3
  • Rhode Island Hospital, Providence
365 Days – 25 Years · All sexes · Updated Aug 25, 2026 · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

RecruitingPhase 1
  • Rhode Island Hospital, Providence
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05544019

Burkitt Lymphoma trials in other cities

Other studies in Providence

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.